Preconditioned and Genetically Modified Stem Cells for Myocardial Infarction Treatment.

Raziyeva, Kamila; Smagulova, Aiganym; Kim, Yevgeniy; Smagul, Saltanat; Nurkesh, Ayan; Saparov, Arman

Raziyeva, Kamila; Smagulova, Aiganym; Kim, Yevgeniy; Smagul, Saltanat; Nurkesh, Ayan; Saparov, Arman.

Afiliación

Raziyeva K; Department of Medicine, School of Medicine, Nazarbayev University, Nur-Sultan 010000, Kazakhstan.
Smagulova A; Department of Medicine, School of Medicine, Nazarbayev University, Nur-Sultan 010000, Kazakhstan.
Kim Y; Department of Medicine, School of Medicine, Nazarbayev University, Nur-Sultan 010000, Kazakhstan.
Smagul S; Department of Medicine, School of Medicine, Nazarbayev University, Nur-Sultan 010000, Kazakhstan.
Nurkesh A; Department of Medicine, School of Medicine, Nazarbayev University, Nur-Sultan 010000, Kazakhstan.
Saparov A; Department of Medicine, School of Medicine, Nazarbayev University, Nur-Sultan 010000, Kazakhstan.

Int J Mol Sci ; 21(19)2020 Oct 02.

Article en En | MEDLINE | ID: mdl-33023264

Asunto(s)

Trasplante de Células Madre Mesenquimatosas; Infarto del Miocardio/terapia; Miocardio/metabolismo; Regeneración/genética; Animales; Apoptosis/genética; Humanos; Células Madre Mesenquimatosas/citología; Infarto del Miocardio/genética; Infarto del Miocardio/patología; Miocardio/patología; Regeneración/fisiología; Transducción de Señal/genética

Palabras clave

cell reprogramming; genetic modification; myocardial infarction; stem cell differentiation; stem cell preconditioning; stem cell therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Regeneración / Trasplante de Células Madre Mesenquimatosas / Infarto del Miocardio / Miocardio Idioma: En Revista: Int J Mol Sci Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google